Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 18.31B | 28.63B | 14.80B | 29.03B | 5.31B |
Gross Profit | 5.71B | 5.29B | 5.53B | 9.69B | 866.03M |
EBITDA | 3.14B | 3.54B | 4.90B | 8.18B | -1.00B |
Net Income | 1.10B | 1.82B | 3.73B | 3.51B | -1.06B |
Balance Sheet | |||||
Total Assets | 62.10B | 55.23B | 49.90B | 39.39B | 25.75B |
Cash, Cash Equivalents and Short-Term Investments | 9.41B | 16.39B | 8.73B | 5.70B | 2.16B |
Total Debt | 30.33B | 29.79B | 29.64B | 23.75B | 16.19B |
Total Liabilities | 42.70B | 36.68B | 34.12B | 28.46B | 17.13B |
Stockholders Equity | 19.40B | 18.55B | 15.79B | 10.93B | 7.59B |
Cash Flow | |||||
Free Cash Flow | -3.61B | 6.72B | -3.36B | 19.23B | -3.76B |
Operating Cash Flow | -3.08B | 7.03B | -3.26B | 19.28B | -3.72B |
Investing Cash Flow | -3.85B | -457.44M | -314.78M | -4.59B | -315.54M |
Financing Cash Flow | 1.92B | -1.23B | 6.59B | -11.23B | 1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | £5.47B | 8.78 | 9.49% | 5.10% | 10.05% | -13.15% | |
64 Neutral | ¥19.64B | 12.58 | 1.95% | -30.94% | 26.14% | ||
― | €148.93M | 20.48 | 4.48% | ― | ― | ― | |
73 Outperform | ¥17.64B | 6.61 | 5.13% | 17.92% | 15.44% | ||
68 Neutral | ¥15.42B | 223.80 | 2.77% | 11.20% | -93.41% | ||
61 Neutral | ¥15.06B | 10.31 | 6.16% | 22.01% | 26.92% | ||
39 Underperform | ¥8.04B | ― | ― | -17.04% | 46.36% |